RIDGEVIEW INSTITUTE SMYRNA
1. Target Overview & Investment Thesis
RIDGEVIEW INSTITUTE SMYRNA is a 188-bed suburban community hospital in COBB, GA with $40.1M in net patient revenue and a 20.8% operating margin. The hospital serves a payer mix of 11.3% Medicare, 0.4% Medicaid, and 88.2% commercial.
Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 20.8% to 28.1% (+736bps).
| Net Revenue HCRIS | $40.1M |
| Current EBITDA COMPUTED | $8.3M |
| Operating Margin COMPUTED | 20.8% |
| Occupancy HCRIS | 65.3% |
| Revenue / Bed COMPUTED | $213K |
| Net-to-Gross HCRIS | 38.7% |
| Distress Probability ML | 45.7% |
2. Market Context & Competitive Position
GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of 20.8% places it above the state median. Among 50 size-comparable peers (94-376 beds), the median margin is 0.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (94-376), prioritizing same-state peers. 50 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RIDGEVIEW INSTITUTE SMYRNA (Target) | GA | 188 | $40.1M | 20.8% |
| EGLESTON CHILDRENS HOSPITAL AT | GA | 330 | $941.9M | 41.5% |
| SCOTTISH RITE CHILDRENS MEDICA | GA | 319 | $905.6M | 44.8% |
| COBB HOSPITAL AND MEDICAL CENT | GA | 367 | $897.0M | 6.1% |
| PHOEBE PUTNEY MEMORIAL HOSPITA | GA | 338 | $665.5M | -7.1% |
| NORTHSIDE HOSPITAL-CHEROKEE I | GA | 212 | $623.5M | -0.1% |
| ST. JOSEPHS OF ATLANTA | GA | 344 | $552.5M | 2.5% |
| PIEDMONT FAYETTE HOSPITAL INC. | GA | 294 | $516.0M | 13.2% |
| FLOYD MEDICAL CENTER | GA | 227 | $481.7M | 13.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $842K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $801K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $793K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $488K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $26K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $8.3M |
| + RCM Uplift | +$2.9M |
| Pro Forma EBITDA | $11.3M |
| Current Margin | 20.8% |
| Pro Forma Margin | 28.1% |
| WC Released (1x) | $1.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $12.8M | $84.4M | 6.59x | 45.8% |
| Base (11x exit) | 10.0x | 11.0x | $12.8M | $97.0M | 7.58x | 49.9% |
| Bull Case | 9.0x | 11.0x | $11.5M | $110.9M | 9.62x | 57.3% |
| Bull (12x exit) | 9.0x | 12.0x | $11.5M | $124.4M | 10.79x | 60.9% |
| Bear Case | 11.0x | 10.0x | $14.1M | $65.5M | 4.65x | 36.0% |
| Bear (11x exit) | 11.0x | 11.0x | $14.1M | $76.6M | 5.44x | 40.3% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 50 hospitals with 94-376 beds
- Same-state prioritization (n=51)
- Comp margins: P25=-11.4% / P50=0.2% / P75=8.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.